Log in

NASDAQ:MDRX - Allscripts Healthcare Solutions Stock Price, Forecast & News

-0.15 (-2.23 %)
(As of 03/29/2020 02:47 PM ET)
Today's Range
Now: $6.59
50-Day Range
MA: $7.49
52-Week Range
Now: $6.59
Volume2.60 million shs
Average Volume3.64 million shs
Market Capitalization$1.07 billion
P/E RatioN/A
Dividend YieldN/A
Allscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. The company operates in two segments, Clinical and Financial Solutions and Population Health. The Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related software, connectivity and coordinated care solutions, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, revenue cycle management, training, and electronic claims administration services. The Population Health segment offers health management, and financial management and patient engagement solutions to hospitals, health systems, accountable care organizations, and other care facilities. The company serves physicians, hospitals, governments, health systems, health plans, life-sciences companies, retail clinics, retail pharmacies, pharmacy benefit managers, insurance companies, and employer wellness clinics, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
Read More
Allscripts Healthcare Solutions logo

Industry, Sector and Symbol

Industry Computer integrated systems design
Sub-IndustryHealth Care Technology
Current SymbolNASDAQ:MDRX



Sales & Book Value

Annual Sales$1.77 billion
Cash Flow$2.01 per share
Book Value$7.92 per share


Net Income$-182,180,000.00


Market Cap$1.07 billion
Next Earnings Date5/7/2020 (Estimated)

Receive MDRX News and Ratings via Email

Sign-up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter.

Allscripts Healthcare Solutions (NASDAQ:MDRX) Frequently Asked Questions

How has Allscripts Healthcare Solutions' stock been impacted by COVID-19 (Coronavirus)?

Allscripts Healthcare Solutions' stock was trading at $6.31 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, MDRX shares have increased by 4.4% and is now trading at $6.59. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Allscripts Healthcare Solutions?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last year. There are currently 1 sell rating, 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Allscripts Healthcare Solutions.

When is Allscripts Healthcare Solutions' next earnings date?

Allscripts Healthcare Solutions is scheduled to release its next quarterly earnings announcement on Thursday, May 7th 2020. View our earnings forecast for Allscripts Healthcare Solutions.

How were Allscripts Healthcare Solutions' earnings last quarter?

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) posted its quarterly earnings data on Monday, March, 2nd. The software maker reported $0.17 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.18 by $0.01. The software maker had revenue of $452 million for the quarter, compared to the consensus estimate of $457.47 million. Allscripts Healthcare Solutions had a positive return on equity of 5.71% and a negative net margin of 10.28%. The business's revenue for the quarter was down 16.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.20 earnings per share. View Allscripts Healthcare Solutions' earnings history.

How will Allscripts Healthcare Solutions' stock buyback program work?

Allscripts Healthcare Solutions declared that its board has authorized a share repurchase plan on Thursday, August 2nd 2018, which permits the company to repurchase $250,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to repurchase up to 11.3% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's board believes its shares are undervalued.

What guidance has Allscripts Healthcare Solutions issued on next quarter's earnings?

Allscripts Healthcare Solutions issued an update on its first quarter 2020 After-Hours earnings guidance on Monday, March, 2nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $420-430 million, compared to the consensus revenue estimate of $450.84 million.

What price target have analysts set for MDRX?

10 brokerages have issued 12 month target prices for Allscripts Healthcare Solutions' stock. Their forecasts range from $6.00 to $13.00. On average, they anticipate Allscripts Healthcare Solutions' share price to reach $10.25 in the next twelve months. This suggests a possible upside of 55.5% from the stock's current price. View analysts' price targets for Allscripts Healthcare Solutions.

What are Wall Street analysts saying about Allscripts Healthcare Solutions stock?

Here are some recent quotes from research analysts about Allscripts Healthcare Solutions stock:
  • 1. According to Zacks Investment Research, "Allscripts ended the third quarter on a mixed note. The company continues to gain from the core Client Services unit, which displayed an improved performance in the quarter. Significant growth in third-quarter bookings also buoys optimism. The company continues to maintain momentum in its Provider business on the back of key client wins across solution set. The company is confident about its near and long-term outlook as it anticipates to benefit from a number of differentiated growth opportunities in both Provider and Veradigm businesses. However, the company witnessed a contraction in both gross and operating margins in the third quarter. It is also exposed to integration risks. Intense competition in the niche space is an added concern. Over the past year, Allscripts has underperformed its industry." (12/3/2019)
  • 2. Cantor Fitzgerald analysts commented, ". We reiterate our Neutral rating on MDRX shares and maintain our price target at $10, After the market close on Thursday, May 2, MDRX reported 1Q19 results, with revenue slightly below our estimate. 1Q19 bookings increased 9% y/y. MDRX reiterated its 2019 guidance for non-GAAP EPS and bookings. The company continues its policy of not providing full year revenue guidance, but provided 2Q19 revenue guidance, which was below our estimate but in line with FactSet consensus. We note the company had previously provided a modest three-year CAGR outlook." (5/2/2019)

Has Allscripts Healthcare Solutions been receiving favorable news coverage?

Media headlines about MDRX stock have trended extremely negative recently, InfoTrie reports. The research firm ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Allscripts Healthcare Solutions earned a media sentiment score of -4.0 on InfoTrie's scale. They also assigned news articles about the software maker a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news aboutAllscripts Healthcare Solutions.

Are investors shorting Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions saw a decrease in short interest during the month of March. As of March 13th, there was short interest totaling 23,790,400 shares, a decrease of 13.3% from the February 27th total of 27,440,000 shares. Based on an average daily trading volume, of 3,768,500 shares, the short-interest ratio is presently 6.3 days. Currently, 15.0% of the company's shares are short sold. View Allscripts Healthcare Solutions' Current Options Chain.

Who are some of Allscripts Healthcare Solutions' key competitors?

Some companies that are related to Allscripts Healthcare Solutions include Cerner (CERN), Omnicell (OMCL), HMS (HMSY), Cortexyme (CRTX), HealthStream (HSTM), Vocera Communications (VCRA) and Computer Programs & Systems (CPSI).

What other stocks do shareholders of Allscripts Healthcare Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Allscripts Healthcare Solutions investors own include Advanced Micro Devices (AMD), Netflix (NFLX), Walgreens Boots Alliance (WBA), Starbucks (SBUX), Activision Blizzard (ATVI), Nuance Communications (NUAN), AK Steel (AKS), Ford Motor (F), Oasis Petroleum (OAS) and American Airlines Group (AAL).

Who are Allscripts Healthcare Solutions' key executives?

Allscripts Healthcare Solutions' management team includes the following people:
  • Mr. Paul M. Black, CEO & Director (Age 61)
  • Mr. Richard J. Poulton, Pres (Age 54)
  • Mr. Dennis M. Olis, Chief Financial Officer (Age 56)
  • Mr. Brian P. Farley, Exec. VP, Gen. Counsel, Corp. Sec. & Chief Admin. Officer (Age 49)
  • Ms. Lisa Khorey, Exec. VP & Chief Client Delivery Officer (Age 52)

What is Allscripts Healthcare Solutions' stock symbol?

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

Who are Allscripts Healthcare Solutions' major shareholders?

Allscripts Healthcare Solutions' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include State Street Corp (3.20%), Tamarack Advisers LP (2.25%), Geode Capital Management LLC (1.75%), Jacobs Levy Equity Management Inc. (1.64%), Prudential Financial Inc. (1.52%) and Penn Capital Management Co. Inc. (1.08%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, Mara G Aspinall, Michael Klayko, Paul Black, Richard J Poulton and Yancey L Spruill. View institutional ownership trends for Allscripts Healthcare Solutions.

Which institutional investors are selling Allscripts Healthcare Solutions stock?

MDRX stock was sold by a variety of institutional investors in the last quarter, including Tamarack Advisers LP, Fort Washington Investment Advisors Inc. OH, State Street Corp, Rothschild & Co. Asset Management US Inc., Royce & Associates LP, Adirondack Research & Management Inc., Penn Capital Management Co. Inc., and Principal Financial Group Inc.. View insider buying and selling activity for Allscripts Healthcare Solutions.

Which institutional investors are buying Allscripts Healthcare Solutions stock?

MDRX stock was bought by a variety of institutional investors in the last quarter, including Norges Bank, Man Group plc, Jacobs Levy Equity Management Inc., Smith Graham & Co. Investment Advisors LP, California Public Employees Retirement System, LMR Partners LLP, Sculptor Capital LP, and Cubist Systematic Strategies LLC. Company insiders that have bought Allscripts Healthcare Solutions stock in the last two years include Mara G Aspinall, Michael Klayko, Paul Black, Richard J Poulton, and Yancey L Spruill. View insider buying and selling activity for Allscripts Healthcare Solutions.

How do I buy shares of Allscripts Healthcare Solutions?

Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Allscripts Healthcare Solutions' stock price today?

One share of MDRX stock can currently be purchased for approximately $6.59.

How big of a company is Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions has a market capitalization of $1.07 billion and generates $1.77 billion in revenue each year. The software maker earns $-182,180,000.00 in net income (profit) each year or $0.47 on an earnings per share basis. Allscripts Healthcare Solutions employs 9,600 workers across the globe. View additional information about Allscripts Healthcare Solutions.

What is Allscripts Healthcare Solutions' official website?

The official website for Allscripts Healthcare Solutions is http://www.allscripts.com/.

How can I contact Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at 800-334-8534 or via email at [email protected]

MarketBeat Community Rating for Allscripts Healthcare Solutions (NASDAQ MDRX)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  605 (Thanks for Voting!)
Underperform Votes:  658 (Thanks for Voting!)
Total Votes:  1,263
MarketBeat's community ratings are surveys of what our community members think about Allscripts Healthcare Solutions and other stocks. Vote "Outperform" if you believe MDRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel